Hyperlipoproteinemia Type 5
Symptoms, Doctors, Treatments, Advances & More

Hyperlipoproteinemia Type 5 Overview

Save information for later
Sign Up

Learn About Hyperlipoproteinemia Type 5

What is the definition of Hyperlipoproteinemia Type 5?
Hyperlipoproteinemia type V is a disorder of blood plasma fats (lipids) that can be inherited or acquired that is characterized by very low density lipoprotein, decreased low density lipoprotein (LDL), and high density lipoprotein (HDL). Hyperlipoproteinemia type V can increase the risk of developing cardiovascular diseases, such as stroke or heart attack.
What are the symptoms of Hyperlipoproteinemia Type 5?
Most individuals with hyperlipoproteinemia type V do not have any symptoms. The disease is usually discovered during an examination or upon symptoms of a stroke or heart attack. Some individuals with hyperlipoproteinemia type V may develop xanthomas (small, round, and whitish cholesterol deposits under the skin), especially around the eyes, and hypertriglyceridemic waist, which is an increased waist circumference > 90 cm in men or >85 cm in women.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hyperlipoproteinemia Type 5?
Treatment for hyperlipoproteinemia type V includes medications administered alone or in combination such as statins (lovastatin, simvastatin, atorvastatin, or rosuvastatin), bile acid binding resins (cholestyramine or colestipol), fibric acid derivatives (gemfibrozil or bezafibrate), nicotinic acid derivatives (Niacin), and cholesterol absorption inhibitors (ezetimbe).
Who are the top Hyperlipoproteinemia Type 5 Local Doctors?
Experienced in Hyperlipoproteinemia Type 5
Dr. Andrij Baran
Cardiology | Cardiac Electrophysiology | Internal Medicine
Experienced in Hyperlipoproteinemia Type 5
Dr. Andrij Baran
Cardiology | Cardiac Electrophysiology | Internal Medicine

St. Peter's Health Partners Medical Associates, P.C.

2 New Hampshire Ave, 
Troy, NY 
518-525-8220
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Andrij Baran is a Cardiologist and an Internal Medicine provider practicing medicine in Troy, New York. Dr. Baran is rated as an Experienced provider by MediFind in the treatment of Hyperlipoproteinemia Type 5. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Heart Failure with Preserved Ejection Fraction (HFpEF), High Cholesterol, Heart Failure, and Pacemaker Implantation. Dr. Baran is currently accepting new patients.

Advanced in Hyperlipoproteinemia Type 5
Dr. Christopher D. Powers
Cardiology | Internal Medicine
Advanced in Hyperlipoproteinemia Type 5
Dr. Christopher D. Powers
Cardiology | Internal Medicine

OSF Cardiovascular Institute

3375 North Seminary Street, 
Galesburg, IL 
309-343-7775
Languages Spoken:
English
See accepted insurances

Christopher Powers is a Cardiologist and an Internal Medicine provider practicing medicine in Galesburg, Illinois. Dr. Powers is rated as an Advanced provider by MediFind in the treatment of Hyperlipoproteinemia Type 5. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Atrial Fibrillation, Fainting, Stable Angina, Angina, and Pacemaker Implantation. Dr. Powers is board certified in American Board Of Internal Medicine.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Hyperlipoproteinemia Type 5
Dr. Jiho Choi
Geriatrics
Distinguished in Hyperlipoproteinemia Type 5
Dr. Jiho Choi
Geriatrics

Immediate Housecalls LLC

4216 Evergreen Ln Ste 121, 
Annandale, VA 
301-893-4124
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jiho Choi is a primary care provider, practicing in Geriatrics in Annandale, Virginia. Dr. Choi is rated as a Distinguished provider by MediFind in the treatment of Hyperlipoproteinemia Type 5. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Shingles, Spasticity, Hyperlipoproteinemia Type 5, and Familial Lipoprotein Lipase Deficiency.

View All Doctors
What are the latest Hyperlipoproteinemia Type 5 Clinical Trials?
A Phase 1 Open-label, Multicenter, First-in-human, Ascending Dose Trial Evaluating the Safety and Tolerability of a Lipid Nanoparticle Formulation of CRISPR-Guide RNA-Cas9 Nuclease (CTX310) for In Vivo Editing of the Angiopoietin-like 3 (ANGPTL3) Gene in Participants With Refractory Dyslipidemias
A Phase 1 Open-label, Multicenter, First-in-human, Ascending Dose Trial Evaluating the Safety and Tolerability of a Lipid Nanoparticle Formulation of CRISPR-Guide RNA-Cas9 Nuclease (CTX310) for In Vivo Editing of the Angiopoietin-like 3 (ANGPTL3) Gene in Participants With Refractory Dyslipidemias
Enrollment Status: Recruiting
Publish Date: March 24, 2026
Intervention Type: Drug
Study Phase: Phase 1

Summary: This is a single-arm, open-label, multicenter, ascending dose Phase 1 trial that will enroll participants 18 to 75 years of age with dyslipidemias that are refractory to available treatments.

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials